Skip to main content

Month: February 2024

Jones Soda Sets Fourth Quarter and Full Year 2023 Conference Call for Thursday, March 14, 2024, at 4:30 p.m. ET

SEATTLE, Feb. 29, 2024 (GLOBE NEWSWIRE) — Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), the original craft soda known for its great tastes, unconventional flavors and user-submitted photo labels, will hold a conference call on Thursday, March 14, 2024, at 4:30 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2023. The financial results will be reported in a press release prior to the conference call. Jones Soda management will host the conference call, followed by a live question-and-answer period. Investors and analysts are encouraged to dial into the call with any questions they would like management to address. Date: Thursday, March 14, 2024Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-877-407-0784International...

Continue reading

Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing

GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) — Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”), a global leader in decentralized cell and gene therapies (CGTs), today announced that the Company’s consortium was awarded a €2.0 million grant from the Walloon Government in Belgium, titled: “Monitoring with AI of Decentralized ATMP Manufacturing” (MAIDAM). The consortium members include: Orgenesis Services Belgium, Université catholique de Louvain (UCLouvain) / TRusted AI Labs (TRAIL) and DNAlytics. Advanced Therapy Medicinal Products (ATMPs) are among the most innovative and promising biomedicines designed to address unmet medical needs, including cell, gene, exosome and phage therapies. On January 17, 2024, the Walloon government launched a partnership, ATMP-Partenariat d’Innovation Technologique (ATMP-PIT), with an...

Continue reading

VERB’S MARKET.live Second Frankie Avalon Livestream Shopping Show Draws More Than 25,000 Viewers 

Third Show in the Weekly Series Broadcasts Live Today at 3pm PT/ 6pm ET on MARKET.live and Social Media Channels LOS ALAMITOS, Calif. and LAS VEGAS, Feb. 29, 2024 (GLOBE NEWSWIRE) — Get ready for another extraordinary livestream shopping experience as Verb Technology Company, Inc. (Nasdaq: VERB) proudly presents the third episode of the exclusive Frankie Avalon Livestream Shopping Series on MARKET.live. Join us today, Thursday, February 29th, at 3 pm PT / 6 pm ET for an immersive journey into love, music, and wellness with the legendary entertainer, Frankie Avalon, co-hosted by the charismatic Albany Irvin.  Event Details: Date/Time: Thursday, February 29th at 3 pm PT / 6 pm ET  Co-Hosts: Frankie Avalon and Albany Irvin (albanyirvin.com) The previous livestream event drew an incredible audience of well over 25,000 viewers across...

Continue reading

CytoDyn Announces FDA Has Lifted Clinical Hold

Webcast to Provide Company Update on March 5, 2024 VANCOUVER, Washington, Feb. 29, 2024 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the FDA has lifted the clinical hold on leronlimab. The Company is now free to proceed with its proposed HIV clinical trial exploring leronlimab and its effects on chronic inflammation. CytoDyn’s CEO, Dr. Jacob Lalezari, stated, “We are excited that the clinical hold on leronlimab has been lifted by the FDA. CytoDyn is grateful for the FDA’s guidance on our protocol and we are excited to open a new chapter in the development of leronlimab as a therapy that provides clinical benefit by...

Continue reading

Moblico Partners with Bridgeline’s HawkSearch to Introduce AI-driven Mobile Product Search for Distributors

WOBURN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, today announced its partnership with Moblico, a leader in mobile engagement solutions for wholesale distributors, providing mobile messaging and custom branded mobile apps. Moblico will leverage Bridgeline’s HawkSearch to grow revenue for distributors through mobile search. The partnership combines Moblico’s mobile engagement solutions with HawkSearch’s AI search technology, enabling distributors to interact with customers in real-time, increasing customer retention and revenue. Moblico has extended its expertise to thousands of wholesale distribution centers and manufacturers across the US, Canada, Mexico, Latin America, and Europe. Similarly, HawkSearch brings a proven track record of working...

Continue reading

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Precedent-setting submission includes data from post-marketing studies COBALT and Study 401 as well as real-world evidence from a claims database and patient registries FDA has assigned a PDUFA target action date of October 15, 2024MORRISTOWN, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for Ocaliva for the treatment of individuals with primary biliary cholangitis (PBC). The FDA has assigned...

Continue reading

NETSOL’s Calculation Engine Flex Now Empowering Haydock Finance’s Broker Division

ENCINO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, has announced that its customer Haydock Finance is now offering access to NETSOL’s API-based calculation engine Flex to its broker division. Haydock Finance is an award-winning supportive business finance specialist that is using Flex since 2023 and subscribed to additional products from Appex Now earlier this year. Appex Now is the world’s first marketplace for API-first products developed by NETSOL specifically for the global credit, finance and leasing industry. “Our instant cloud-based calculation engine essentially empowers financial institutions with swift and accurate contract lifecycle calculations and seamless integration into a customer’s ecosystem,” said...

Continue reading

HeartCore Signs 12th Go IPO Contract

NEW YORK and TOKYO, Feb. 29, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced that it has signed an agreement (“Consulting Agreement”) with Jyo Co., Ltd. (“Jyo”) for its 12th Go IPO consulting service win. “I am pleased to announce our 12th Go IPO contract win and our first one for 2024,” said HeartCore CEO Sumitaka Kanno Yamamoto. “Demand remains robust as the HeartCore Go IPO brand continues to grow in the Japanese markets and attracts interest from companies seeking to list on a major U.S. exchange. Despite facing headwinds in a volatile IPO market, we continue to shepherd our clients through a typically grueling process with our white glove approach to ensure they’re successfully listed....

Continue reading

BIGG Digital Assets Inc. Wholly Owned Subsidiary TerraZero Technologies Inc. and FINLITI Announce Strategic Partnership to Pioneer the Next Era of Financial Literacy & Investing with TerraZero’s ‘Intraverse’

VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, and Blockchain Intelligence Group and TerraZero is pleased to report that Finliti (“Finliti”), a wealth management software company that uses behavioural science to optimise investment decision making for brokerages and their clients, and TerraZero Technologies Inc. (“TerraZero”), a vertically integrated digital experience development group and leading web3 technology company specializing in helping brands create immersive virtual environments, proudly announce their strategic partnership aimed at revolutionizing financial literacy and access to wealth creation opportunities using the Intraverse...

Continue reading

TOMI Environmental Announces Additional iHP Custom Engineered System Installation Contracted for California

FREDERICK, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the signing of a new contract for a SteraMist iHP Custom Engineered System (CES) installation with a California-based life sciences company. The contracted iHP Custom Engineered System (CES) is valued at approximately $600,000. This system, featuring six applicators, will be integrated into a clinical suite, and is expected to be fully installed by the end of the third quarter in 2024. The life sciences sector is increasingly adopting automation in various processes, including decontamination, to comply with Annex 1, GMP, ISO, and other strict standards. California, a leading hub for the pharmaceutical and biotech industries, is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.